Citigroup’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-30,600
| Closed | -$1.04M | – | 5851 |
|
|
2024
Q3 | $1.04M | Buy |
+30,600
| New | +$1.17M | ﹤0.01% | 3236 |
|
|
2023
Q1 | – | Sell |
-10,000
| Closed | -$446K | – | 5543 |
|
|
2022
Q4 | $446K | Hold |
10,000
| – | – | ﹤0.01% | 3252 |
|
|
2022
Q3 | $281K | Sell |
10,000
-110,000
| -92% | -$3.37M | ﹤0.01% | 3592 |
|
|
2022
Q2 | $3.23M | Sell |
120,000
-60,000
| -33% | -$1.74M | ﹤0.01% | 1779 |
|
|
2022
Q1 | $6.13M | Hold |
180,000
| – | – | 0.01% | 1564 |
|
|
2021
Q4 | $6.96M | Buy |
+180,000
| New | +$7.84M | 0.01% | 1616 |
|
|
2019
Q4 | – | Sell |
-4,700
| Closed | -$10K | – | 7677 |
|
|
2019
Q3 | $10K | Sell |
4,700
-318
| -6% | -$736 | ﹤0.01% | 7056 |
|
|
2019
Q2 | $13K | Buy |
+5,018
| New | +$17K | ﹤0.01% | 7222 |
|
|
2018
Q3 | – | Sell |
-927
| Closed | -$7K | – | 7751 |
|
|
2018
Q2 | $7K | Sell |
927
-880
| -49% | -$11.8K | ﹤0.01% | 7270 |
|
|
2018
Q1 | $63K | Sell |
1,807
-140
| -7% | -$5.42K | ﹤0.01% | 5990 |
|
|
2017
Q4 | $83K | Sell |
1,947
-1,166
| -37% | -$49.9K | ﹤0.01% | 5804 |
|
|
2017
Q3 | $134K | Buy |
3,113
+1,766
| +131% | +$66.2K | ﹤0.01% | 5317 |
|
|
2017
Q2 | $50K | Buy |
1,347
+614
| +84% | +$27.2K | ﹤0.01% | 5790 |
|
|
2017
Q1 | $40K | Sell |
733
-507
| -41% | -$26.4K | ﹤0.01% | 5851 |
|
|
2016
Q4 | $66K | Buy |
1,240
+353
| +40% | +$20.1K | ﹤0.01% | 6007 |
|
|
2016
Q3 | $54K | Sell |
887
-1,120
| -56% | -$69.7K | ﹤0.01% | 5615 |
|
|
2016
Q2 | $132K | Sell |
2,007
-1,660
| -45% | -$105K | ﹤0.01% | 4849 |
|
|
2016
Q1 | $208K | Buy |
3,667
+774
| +27% | +$87.1K | ﹤0.01% | 5054 |
|
|
2015
Q4 | $681K | Buy |
2,893
+1,220
| +73% | +$266K | ﹤0.01% | 3540 |
|
|
2015
Q3 | $265K | Buy |
1,673
+653
| +64% | +$185K | ﹤0.01% | 4285 |
|
|
2015
Q2 | $386K | Buy |
+1,020
| New | +$405K | ﹤0.01% | 3943 |
|
Other funds holding CLDX
KCM
VCM
CC
EP